Back to search

National and Kapodistrian University of Athens

Μελέτη πολυμορφισμών γονιδίων αποτοξίνωσης σε ασθενείς με πολλαπλή σκλήρυνση

Abstract

dc:description

Introduction: Multiple Sclerosis (MS) is a major, inflammatory anddemyelinating, chronic disorder of the Central Nervous System (CNS),affecting most commonly young adults. It is generally considered to be anautoimmune disease and is characterized by multifocal damage of the CNS. Itis characterized by a variety with regard to the age of onset, the neurologicalmanifestations, the evolution and the disability level. The cause of MS isunknown; however, it is thought to be interplay between genetic andenvironmental factors. According to recent surveys the role of oxidative stressin MS susceptibility seems to be dominant. During the inflammatory events ofthe disease, a variety of reactive oxygen species (ROS) are produced, whichare potentially toxic. When the cellular capacity to neutralize ROS fails,oxidative stress occurs with detrimental effects on lipid membranes, proteinsand astrocytes’ nucleotides. Exogenous and endogenous products ofoxidative stress are metabolized by antioxidant phase I and II enzymes.The most significant enzymes of phase II are those that belong to glutathione-S-transferase family (GSTs) and the NQO1 reductase. GSTP1 enzymeactivity strongly depends on a single nucleotide polymorphism (SNP) at theGSTP1 gene locus. This A→G substitution at nucleotide 313 (A313G), resultsin an isoleucine to valine substitution (Ile105Val), affecting substrate-specificcatalytic activity and thermal stability of the encoded protein. Thus, individualshomozygous for the variant G allele (G/G) have a lower conjugating activitythan individuals homozygous for the wild type A allele (A/A), whileheterozygotes (A/G) display intermediate activity.The other two genes of the glutathione-S-transferase family (GSTs) Τ1 andΜ1 exhibit an inherited homozygous deletion polymorphism (null genotype)resulting the total absence of enzymatic activity in humans. The NAD(P)Hquinine oxidoreductase (NQO1) catalytic enzyme activity also stronglydepends on a single nucleotide polymorphism (SNP) (C609T). This C→Tsubstitution at nucleotide 187 (C609T), results in a proline-to-serinesubstitution at amino acid 187 of the mature protein that destabilizes andinactivates the enzyme. Individuals homozygous for the mutant allele (T/T)completely lack NQO1 activity, whereas heterozygotes (C/T) presentdecreased enzyme activity. Objective: The aim of the present study was to investigate, for the first time inGreek patients with MS, the possible association of specific polymorphisms ofGSTP1, GSTM1, GSTT1 και NQO1 genes with both the susceptibility to andthe clinical characteristics of the disease.Materials and methods: Genotypes were determined from 254 Greekpatients (94 males and 160 females) with clinically definite MS (based on McDonald’s criteria) and 370 (188 males and 182 females) healthy controls. Themean age of the disease onset was 35 years (18-83 years), whereas themean age of the controls was 50 years (20-85 years). Informed consent hasbeen obtained from all patients and controls and study was approved by theScientific Committee of the National and Kapodistrian University of Athens,that is, responsible for ethics. The Disability was assessed using the KurtzkeExpanded Disability Status Scale (EDSS) and the patients were stratified tothose mild disability (EDSS:0-4), moderate (EDSS:4,5-5,5) and severe(EDSS:6-10). Clinical data were available for 240 out of 254 patients. Patientswere also categorized according to their clinical subtype; RRMS (RelapsingRemitting MS), RPMS (Relapsing Progressing MS), PPMS (PrimaryProgressive MS) και SPMS (Secondary Progressive MS).Polymerase chain reaction (PCR) techniques were used to determine theabove polymorphisms; restriction fragment length polymorphism (PCR-RFLP)and real time PCR were used for GSTP1 A313G and NQO1 C609Tpolymorphisms. The multiplex PCR was used to identify The GSTT1 καιGSTM1 null polymorphisms.Pearson’s chi square test was used for the statistical analysis of the genotypecontribution and the rest of the variable parameters evaluation (statisticallysignificant at the 95% level, p=0,05).Results: The major finding of this study is the significantly higher frequency ofheterozygous (C/T) and homozygous (T/T) individuals for the NQO1polymorphism observed among MS patients compared to controls.Interestingly, there is 3.7- fold possibility for MS patients to be T/T comparedto the donors. Considering allele frequencies our analysis showed a 1.5-foldincreased risk for MS patients to be carriers of at least one variant T allele,compared to controls. Classification of MS patients according to clinicalsubtypes revealed a higher frequency of homozygous (T/T) and heterozygous (C/T) individuals among patients belonging to the PPMS (Primary ProgressiveMultiple Sclerosis) subgroup, compared to the other MS subtypes. This resultwas confirmed by the allele frequency distribution analysis, with a higher Tallele frequency among PPMS patients. According to gender, a significanthigher frequency of A allele contribution was observed among female controls(1.5-fold). Interpreting the results, there is the likelihood of a protective role ofvariant A allele to females. Regarding classification of patients in clinicalsubtypes, a higher frequency of heterozygous A/G ones was observed inRRMS (Relapsing Remitting Multiple Sclerosis), as compared to the controls.The results of the present work suggest a putative role for the GSTP1heterozygosity in the RRMS subtype, especially in those presenting EDSS ≤2after 10-15 years from the disease onset. In MS patients there is an increasedfrequency of combined GSTP1 heterozygosity and NQO1 heterozygosity orNQO1 homozygosity T/T compared to controls (P- value=0.035, x2=5.33,d.f.=1, OR=0.56, 95%CI=0.345-0.919).With regard to GSTΜ1 polymorphism there is 2-fold risk and 1,8-fold risk forfemale patients to be GSTΜ1 null compared to the male patients and thefemale controls respectively.Conclusions: In conclusion, our present findings are consistent with apossible effect of the C609T NQO1 inborn polymorphism on MS susceptibility.Additionally, it is suggested that C609T NQO1 and A313G GSTP1polymorphisms are involved in the clinical manifestation of the disease. Thecombined GSTP1 and NQO1 variant genotypes may suggest that defectivefunction of detoxification enzymes might have an effect on MS susceptibility.GSTΜ1 null και ο GSTP1 A313G polymorphisms influence the MS evolution ina gender depended manner. With regard to GSTΤ1 null polymorphismfrequency contribution no significant statistical difference was found betweenthe group of patients and controls.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Alexoudi, Athanasia
  • Αλεξούδη, Αθανασία

Subjects

dc:subject × 18

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/42139

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Alexoudi, Athanasia; Αλεξούδη, Αθανασία. Μελέτη πολυμορφισμών γονιδίων αποτοξίνωσης σε ασθενείς με πολλαπλή σκλήρυνση. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/42139